Association of FGFR4 Mutation With Immunotherapy Outcomes in Patients With Cancer

被引：0
|
作者：
Cui, L. [1 ]
Zhang, Y. [1 ]
Zhao, Z. [2 ]
Bai, Y. [1 ]
Liu, L. [3 ]
机构：
[1] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[2] 3D Med Inc, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
FGFR4; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.07
引用
收藏
页码：S576 / S576
页数：1
相关论文
共 50 条
  • [31] First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
    Hagel, Margit
    Miduturu, Chandra
    Sheets, Michael
    Rubin, Nooreen
    Weng, Weifan
    Stransky, Nicolas
    Bifulco, Neil
    Kim, Joseph L.
    Hodous, Brian
    Brooijmans, Natasja
    Shutes, Adam
    Winter, Christopher
    Lengauer, Christoph
    Kohl, Nancy E.
    Guzi, Timothy
    CANCER DISCOVERY, 2015, 5 (04) : 424 - 437
  • [32] Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer
    Ansell, Anna
    Farnebo, Lovisa
    Grenman, Reidar
    Roberg, Karin
    Thunell, Lena K.
    ORAL ONCOLOGY, 2009, 45 (01) : 23 - 29
  • [33] Dysregulation in IGF-1R, FGFR4 and βKlotho signaling in patients with medullary thyroid cancer
    Motylewska, Ewelina
    Borkowska, Magdalena
    Lawnicka, Hanna
    Kuzdak, Krzysztof
    Siejka, Agnieszka
    Swietoslawski, Jacek
    Stepien, Henryk
    Stepien, Tomasz
    NEUROENDOCRINOLOGY LETTERS, 2019, 40 (01) : 29 - 35
  • [34] The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients
    Ye, Yan-Wei
    Zhang, Xiefu
    Zhou, Ye
    Wu, Jianghong
    Zhao, Chunlin
    Yuan, Lin
    Wang, Guojun
    Du, Chunyan
    Wang, Chunmeng
    Shi, Yingqiang
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (07) : 872 - 879
  • [35] The Role FGFR4 in Pancreatic Endocrine Tumors
    Serra, S.
    Ezzat, S.
    Chetty, R.
    Asa, S. L.
    LABORATORY INVESTIGATION, 2009, 89 : 120A - 120A
  • [36] FGFR4 GLY388ARG polymorphism modulates cancer patients' survival in pooled analysis
    Elisa Frullanti
    Tommaso A Dragani
    BMC Proceedings, 4 (Suppl 2)
  • [37] FIRST SELECTIVE SMALL MOLECULE INHIBITOR OF FGFR4 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS WITH AN ACTIVATED FGFR4 SIGNALING PATHWAY
    Hoeflich, K.
    Hagel, M.
    Miduturu, C.
    Sheets, M.
    Rubin, N.
    Weng, W.
    Stransky, N.
    Bifulco, N.
    Kim, J.
    Hodous, B.
    Brooijmans, N.
    Shutes, A.
    Winter, C.
    Lengauer, C.
    Kohl, N.
    Guzi, T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S215 - S216
  • [38] 靶向FGFR4的miRNA筛选
    高赢政
    蔡琳
    黄佳伟
    邱梦媛
    黄通周
    数理医药学杂志, 2017, 30 (06) : 791 - 794
  • [39] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    LABORATORY INVESTIGATION, 2008, 88 : 110A - 111A
  • [40] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    MODERN PATHOLOGY, 2008, 21 : 110A - 111A
12345